Dosimetric analysis of the brachial plexus among patients with breast cancer treated with post-mastectomy radiotherapy to the ipsilateral supraclavicular area: report of 3 cases of radiation-induced brachial plexus neuropathy

[1] Overgaard M(1999)Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish breast cancer cooperative group DBCG 82c randomised trial Lancet 353 1641-1648

[2] Jensen MB(1997)Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish breast cancer cooperative group 82b Trial N Engl J Med 337 949-955

[3] Overgaard J(2005)Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial J Natl Cancer Inst 97 116-126

[4] Hansen PS(2007)Local recurrence in breast carcinoma patients with T(1–2) and 1–3 positive nodes: indications for radiotherapy Eur J Surg Oncol 33 28-32

[5] Rose C(2002)Locoregional failure of postmastectomy patients with 1–3 positive axillary lymph nodes without adjuvant radiotherapy Int J Radiat Oncol Biol Phys 52 980-988

[6] Andersson M(2010)The clinical value of adjuvant radiotherapy in patients with early stage breast cancer with 1 to 3 positive lymph nodes after mastectomy Chin J Cancer 29 668-676

[7] Kamby C(2005)Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy Int J Radiat Oncol Biol Phys 63 1508-1513

[8] Kjaer M(2014)Progress and controversies: radiation therapy for invasive breast cancer CA Cancer J Clin 64 135-152

[9] Gadeberg CC(2013)DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy forinvasive breast cancer Strahlenther Onkol 189 825-833

[10] Rasmussen BB(2004)Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients? Radiother Oncol 71 297-301

[1] Overgaard M(1999)Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish breast cancer cooperative group DBCG 82c randomised trial Lancet 353 1641-1648

[2] Jensen MB(1997)Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish breast cancer cooperative group 82b Trial N Engl J Med 337 949-955

[3] Overgaard J(2005)Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial J Natl Cancer Inst 97 116-126

[4] Hansen PS(2007)Local recurrence in breast carcinoma patients with T(1–2) and 1–3 positive nodes: indications for radiotherapy Eur J Surg Oncol 33 28-32

[5] Rose C(2002)Locoregional failure of postmastectomy patients with 1–3 positive axillary lymph nodes without adjuvant radiotherapy Int J Radiat Oncol Biol Phys 52 980-988

[6] Andersson M(2010)The clinical value of adjuvant radiotherapy in patients with early stage breast cancer with 1 to 3 positive lymph nodes after mastectomy Chin J Cancer 29 668-676

[7] Kamby C(2005)Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy Int J Radiat Oncol Biol Phys 63 1508-1513

[8] Kjaer M(2014)Progress and controversies: radiation therapy for invasive breast cancer CA Cancer J Clin 64 135-152

[9] Gadeberg CC(2013)DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy forinvasive breast cancer Strahlenther Onkol 189 825-833

[10] Rasmussen BB(2004)Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients? Radiother Oncol 71 297-301